ArticleJournal of cancer research and clinical oncology2025

Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.

Maximilian N Kinzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.